These verdicts propose that severe SARS-CoV-2 infection in COVID-19 patients can increase blood viscosity by modulating fibrinogen, albumin, lipoproteins, and erythrocyte deformability and aggregations (Figure 1). This evidence concerns the gene ALB and COVID-19.